Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Treprostinil recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Treprostinil (4 total). Check the affected lots below.

Most common reason: Packaging defect (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Treprostinil. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Treprostinil recalls on record

none so far in 2026; 4 on record, newest first
Class II · Moderate risk

Tyvaso (treprostinil)

Defective Delivery System: United Therapeutics is voluntarily recalling a small number of Tyvaso Inhalation Systems with Optineb ON-100/7 and TD-100/A medical devices. These devices may have been programmed with a different software version than intended for the device. If the device has the incorrect software, it may not operate as indicated in the Instructions for Use.

Terminated Packaging defect United Therapeutics Corp. D-1423-2014